北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study
作者: Huang, Xiao-Jun; Wang, Yu; Liu, Dai-Hong; Xu, Lan-Ping; Chen, Huan; Chen, Yu-Hong; Han, Wei; Shi, Hong-Xia; Liu, Kai-Yan
关键词: advanced leukemia ; donor lymphocytes infusion ; granulocyte colony-stimulating factor ; hematopoietic stem cell transplantation
刊名: JOURNAL OF CLINICAL IMMUNOLOGY
发表日期: 2008-07-01
DOI: 10.1007/s10875-008-9193-4
卷: 28, 期:4, 页:390-397
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Immunology
研究领域[WOS]: Immunology
关键词[WOS]: BONE-MARROW-TRANSPLANTATION ; ACUTE MYELOID-LEUKEMIA ; COLONY-STIMULATING FACTOR ; BLOOD PROGENITOR CELLS ; CHEMOTHERAPY ; MALIGNANCIES ; REMISSION
英文摘要:

Purpose We retrospectively evaluated the feasibility and safety of a modified prophylactic donor lymphocytes infusion (DLI) approach in advanced leukemia.

Materials and methods Thirty-three patients with advanced leukemia received modified prophylactic DLI; that is, granulocyte colony-stimulating factor-primed peripheral blood progenitor cells instead of steady-donor lymphocyte harvests were used, and a short-term immunosuppressive agent (cyclosporine A or methotrexate 10 mg once per week for 2 to 4 weeks) was used for prevention of DLI-associated graft versus host disease (GVHD) after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.

Results Thirty-nine infusions were performed in 33 patients. The mononuclear cells and median CD3+ cells infused for DLI were 1-2x10(8) and 0.93x10(6) per kilogram, respectively. Six patients experienced II-IV-grade acute GVHD. Twenty patients developed chronic GVHD. No GVHD-related death or transfusion-related pancytopenia was observed. With an 18-month median follow-up, 16 patients were in disease-free survival, and overall survival at 1 and 1.5 years was 69.0% and 50.2%, respectively.

Conclusions The modified prophylactic DLI strategy might represent a step forward in the treatment of advanced leukemia.

语种: 英语
WOS记录号: WOS:000257456500015
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/55757
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China

Recommended Citation:
Huang, Xiao-Jun,Wang, Yu,Liu, Dai-Hong,et al. Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study[J]. JOURNAL OF CLINICAL IMMUNOLOGY,2008,28(4):390-397.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Huang, Xiao-Jun]'s Articles
[Wang, Yu]'s Articles
[Liu, Dai-Hong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Huang, Xiao-Jun]‘s Articles
[Wang, Yu]‘s Articles
[Liu, Dai-Hong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace